Produkty 52083-48-4

CAS 52083-48-4 występuje w naszej ofercie pod nazwami: 4-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)butanoic acid, 95%, 4-(1,3-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)butanoic acid. Oferty producentów: Combi-blocks, Biosynth. Dostępne opakowania: 5g, 10g, 250mg, 1g, 100mg, 0,5g.

4-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7h-purin-7-yl)butanoic acid, 95%
Combi-blocks
  • opakowanie: 5g, 10g, 250mg, 1g
  • Warianty: 5
Zobacz produkt
4-(1,3-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)butanoic acid
Biosynth
  • opakowanie: 0,5g, 5g
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

4-(1,3-dimethyl-2,6-dioxopurin-7-yl)butanoic acid (CAS 52083-48-4) to związek chemiczny o wzorze sumarycznym C11H14N4O4 i masie molowej 266.25 g/mol. Nazwa systematyczna IUPAC: 4-(1,3-dimethyl-2,6-dioxopurin-7-yl)butanoic acid. InChIKey: KCQMWMWEALWVLJ-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC11H14N4O4
Masa molowa266.25 g/mol
Nazwa IUPAC4-(1,3-dimethyl-2,6-dioxopurin-7-yl)butanoic acid
InChIKeyKCQMWMWEALWVLJ-UHFFFAOYSA-N
SMILESCN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCC(=O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 4-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)butanoic acid, 1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-butyric acid, 4-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)butanoic acid, 4-(1,3-dimethyl-2,6-dioxopurin-7-yl)butanoic acid, 4-(1,3-Dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)butanoic acid, 4-(1,3-dimethyl-2,6-dioxo-purin-7-yl)butanoic acid
Izomery (ten sam wzór sumaryczny)
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-methylpurin-9-yl)oxolane-3,4-diol C11H14N4O4
2-amino-7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one C11H14N4O4
7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one C11H14N4O4
2,4-dinitro-5-piperidin-1-ylaniline C11H14N4O4
1-(2,4-dinitrophenyl)-4-methylpiperazine C11H14N4O4
4-[4-(2-aminoethoxy)-3-methoxyphenyl]-1,2,4-triazolidine-3,5-dione C11H14N4O4
(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid C11H14N4O4
(2R,3R,4R,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol C11H14N4O4
(2R,3S,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol C11H14N4O4
1,3-dimethyl-7-[(4,4,5,5-tetradeuterio-1,3-dioxolan-2-yl)methyl]purine-2,6-dione C11H14N4O4
7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione C11H14N4O4
4-[2,6-dioxo-3,7-bis(trideuteriomethyl)purin-1-yl]butanoic acid C11H14N4O4